Home › Connective Tissue Disorders › New York
Connective Tissue Disorders clinical trials in New York
4 studies for Connective Tissue Disorders are looking for participants at sites in New York.
Cities in New York
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
- GSK Investigational Site, New York
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06716606A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, New York
- GSK Investigational Site, New York
- GSK Investigational Site, New York
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06572384ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Western New York BloodCare, Buffalo
- Northwell Health Hemostasis and Thrombosis Center at Long Island Jewish and Cohen Children's Medical Center, Hyde Park
- Weill Cornell Medical College - New York Presbyterian Hospital, New York
- and 2 more
RecruitingObservational study
All ages · All sexes · Updated Aug 17, 2026 · NCT04398628Undifferentiated Connective Tissue Disease Registry
- Hospital for Special Surgery, New York
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 12, 2026 · NCT02234388From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.